Cargando…
Erythema exsudativum multiforme infolge einer COVID-19-Impfung (BNT162b2)
We report a case of a patient with erythema multiforme major following COVID-19 (coronavirus disease 2019) vaccination. Lesions on skin and mucous membranes developed 48 h after the second dose of the mRNA-vaccine BNT162b2 (Tozinameran, Comirnaty®). Under the application of external glucocorticoids...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530369/ https://www.ncbi.nlm.nih.gov/pubmed/34676438 http://dx.doi.org/10.1007/s00105-021-04911-4 |